D Bunnag

5.1k total citations · 1 hit paper
140 papers, 3.9k citations indexed

About

D Bunnag is a scholar working on Public Health, Environmental and Occupational Health, Parasitology and Small Animals. According to data from OpenAlex, D Bunnag has authored 140 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Public Health, Environmental and Occupational Health, 47 papers in Parasitology and 39 papers in Small Animals. Recurrent topics in D Bunnag's work include Malaria Research and Control (56 papers), Parasites and Host Interactions (45 papers) and Helminth infection and control (36 papers). D Bunnag is often cited by papers focused on Malaria Research and Control (56 papers), Parasites and Host Interactions (45 papers) and Helminth infection and control (36 papers). D Bunnag collaborates with scholars based in Thailand, United Kingdom and Canada. D Bunnag's co-authors include T Harinasuta, Nicholas J. White, Juntra Karbwang, David A. Warrell, Mary Warrell, Swangjai Pungpak, M Riganti, Sornchai Looareesuwan, C Viravan and Kesara Na Bangchang and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Microbiology.

In The Last Decade

D Bunnag

140 papers receiving 3.6k citations

Hit Papers

Dexamethasone Proves Deleterious in Cerebral Malaria 1982 2026 1996 2011 1982 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D Bunnag Thailand 34 2.3k 1.1k 571 401 397 140 3.9k
T Harinasuta Thailand 33 2.5k 1.1× 885 0.8× 726 1.3× 379 0.9× 372 0.9× 152 3.9k
Sornchai Looareesuwan Thailand 32 2.7k 1.2× 1.0k 0.9× 338 0.6× 324 0.8× 80 0.2× 126 4.0k
Antoine Berry France 38 2.1k 0.9× 1.1k 1.0× 217 0.4× 397 1.0× 224 0.6× 146 4.4k
J. Kevin Baird Indonesia 31 3.1k 1.4× 702 0.7× 384 0.7× 142 0.4× 50 0.1× 71 4.0k
S Looareesuwan Thailand 32 2.6k 1.1× 628 0.6× 540 0.9× 198 0.5× 39 0.1× 73 3.3k
Ian M. Hastings United Kingdom 38 2.8k 1.2× 433 0.4× 265 0.5× 283 0.7× 53 0.1× 121 4.0k
Benjamin Mordmüller Germany 41 3.1k 1.4× 1.0k 1.0× 188 0.3× 318 0.8× 108 0.3× 183 5.1k
M Gentilini France 28 1.5k 0.7× 873 0.8× 149 0.3× 144 0.4× 112 0.3× 261 3.5k
H. Kyle Webster Thailand 36 3.1k 1.4× 720 0.7× 400 0.7× 66 0.2× 60 0.2× 122 4.4k
C Viravan Thailand 30 1.4k 0.6× 343 0.3× 356 0.6× 100 0.2× 71 0.2× 70 2.6k

Countries citing papers authored by D Bunnag

Since Specialization
Citations

This map shows the geographic impact of D Bunnag's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D Bunnag with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D Bunnag more than expected).

Fields of papers citing papers by D Bunnag

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D Bunnag. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D Bunnag. The network helps show where D Bunnag may publish in the future.

Co-authorship network of co-authors of D Bunnag

This figure shows the co-authorship network connecting the top 25 collaborators of D Bunnag. A scholar is included among the top collaborators of D Bunnag based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D Bunnag. D Bunnag is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chittamas, S, et al.. (2003). Six-years monitoring the efficacy of the combination of artesunate and mefloquine for the treatment of uncomplicated falciparum malaria.. PubMed. 34(3). 542–5. 2 indexed citations
2.
Bunnag, D, T. Kanda, Juntra Karbwang, et al.. (1997). Two doses of artemether/mefloquine or artesunate/mefloquine combination for multidrug resistant falciparum Malaria.. PubMed. 28(4). 727–30. 7 indexed citations
3.
Pungpak, Swangjai, C Viravan, B Radomyos, et al.. (1997). Opisthorchis viverrini Infection in Thailand: Studies on the Morbidity of the Infection and Resolution Following Praziquantel Treatment. American Journal of Tropical Medicine and Hygiene. 56(3). 311–314. 16 indexed citations
4.
Karbwang, Juntra, Kesara Na‐Bangchang, A Thanavibul, et al.. (1994). Comparison of oral artesunate and quinine plus tetracycline in acute uncomplicated falciparum malaria.. PubMed. 72(2). 233–8. 35 indexed citations
5.
Pukrittayakamee, Sasithon, Ralf Clemens, C Pramoolsinsap, et al.. (1992). Polymorphonuclear leucocyte elastase in Plasmodium falciparum malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene. 86(6). 598–601. 22 indexed citations
6.
Bunnag, D, et al.. (1992). Clinical trials of mefloquine with tetracycline.. PubMed. 23(3). 377–82. 7 indexed citations
7.
Bunnag, D, C Viravan, S Looareesuwan, Juntra Karbwang, & T Harinasuta. (1991). Clinical trial of artesunate and artemether on multidrug resistant falciparum malaria in Thailand. A preliminary report.. PubMed. 22(3). 380–5. 93 indexed citations
8.
Harinasuta, T, et al.. (1990). Liver, lung and intestinal trematodiasis.. 473–489. 14 indexed citations
9.
Karbwang, Juntra, D J Back, D Bunnag, & AM Breckenridge. (1988). Inhibition of tolbutamide metabolism by antimalarial drugs.. PubMed. 19(2). 235–41. 2 indexed citations
10.
Tharavanij, S, et al.. (1988). Detection of antibodies against Opisthorchis viverrini in patients before and after treatment with praziquantel.. PubMed. 19(1). 101–8. 13 indexed citations
11.
Wongratanacheewin, Surasakdi, et al.. (1988). Characterization of Humoral Immune Response in the Serum and Bile of Patients with Opisthorchiasis and Its Application in Immunodiagnosis. American Journal of Tropical Medicine and Hygiene. 38(2). 356–362. 49 indexed citations
12.
Harinasuta, T, et al.. (1987). Mefloquine, sulfadoxine, and pyrimethamine in the treatment of symptomatic falciparum malaria: a double-blind trial for determining the most effective dose.. PubMed. 65(3). 363–7. 20 indexed citations
13.
Pongponratn, Emsri, M Riganti, T Harinasuta, & D Bunnag. (1985). Electron microscopy of the human brain in cerebral malaria.. PubMed. 16(2). 219–27. 37 indexed citations
14.
Radomyos, P, D Bunnag, & T Harinasuta. (1985). Report of Episthmium caninum (Verma, 1935) Yamaguti, 1958 (Digenea: Echinostomatidae) in man.. PubMed. 16(3). 508–11. 10 indexed citations
15.
Harinasuta, T, et al.. (1985). TRIALS OF MEFLOQUINE IN VIVAX AND OF MEFLOQUINE PLUS 'FANSIDAR' IN FALCIPARUM MALARIA. The Lancet. 325(8434). 885–888. 56 indexed citations
16.
Radomyos, P, et al.. (1984). Worms recovered in stools following praziquantel treatment.. Arzneimittelforschung. 34. 1215–1217. 17 indexed citations
17.
Bunnag, D, et al.. (1984). Roentgenographically controlled healing of gallbladder lesions in opisthorchiasis after praziquantel treatment.. PubMed. 34(9B). 1175–7. 18 indexed citations
18.
Sirisinha, Stitaya, et al.. (1984). Evaluation of selected anthelmintic compounds for activity against Opisthorchis viverrini.. PubMed. 35(2). 85–90. 6 indexed citations
19.
Vanijanonta, S, D Bunnag, & T Harinasuta. (1984). Paragonimus heterotremus and other Paragonimus spp. in Thailand: pathogenesis, clinic and treatment.. PubMed. 34(9B). 1186–8. 6 indexed citations
20.
Warrell, Mary, Pravan Suntharasamai, D Bunnag, et al.. (1983). AN ECONOMICAL REGIMEN OF HUMAN DIPLOID CELL STRAIN ANTI-RABIES VACCINE FOR POST-EXPOSURE PROPHYLAXIS. The Lancet. 322(8345). 301–304. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026